Trial Details

Not Recruiting
Basic Information
Clinical ID c5123
Identifier EUCTR2010-022758-18-DE
Trial Title A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Subjects with Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intoleran
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions Moderately to severely active Crohn's disease MedDRA version: 14.1.Level: PT.Classification code 10011401.Term: Crohn's disease.System Organ Class: 10017947 - Gastrointestinal disorders.;Therapeutic area: Diseas
Interventions Trade Name: StelaraProduct Name: UstekinumabProduct Code: CNTO1275Pharmaceutical Form: Solution for injectionINN or Proposed INN: UstekinumabCAS Number: 815610-63-0Current Sponsor code: CNTO1275Other descriptive name: N/A<b
Participant Information
Sponsor Janssen-Cilag International N.V.
City NULL
Country/Region Serbia;United States;Spain;Ireland;Austria;Israel;Italy;United Kingdom;Hungary;Czech Republic;European Union;Canada;Belgium;Brazil;Denmark;Australia;South Africa;Germany;Iceland;New Zealand;Japan;South Korea
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement NULL
Study Design
Study Type Interventional clinical trial of medicinal product
Phase NULL
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL